{"organizations": [], "uuid": "4b6c51591a7f3805c08e17d6c68e258907db082f", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews\r", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-sangamo-and-pfizer-announce-collab/brief-sangamo-and-pfizer-announce-collaboration-for-development-of-zinc-finger-protein-gene-therapy-for-als-idUSFWN1OY0C2", "country": "US", "domain_rank": 408, "title": "BRIEF-Sangamo And Pfizer Announce Collaboration For Development Of Zinc Finger Protein Gene Therapy For Als", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-01-03T14:36:00.000+02:00", "replies_count": 0, "uuid": "4b6c51591a7f3805c08e17d6c68e258907db082f"}, "author": "", "url": "https://www.reuters.com/article/brief-sangamo-and-pfizer-announce-collab/brief-sangamo-and-pfizer-announce-collaboration-for-development-of-zinc-finger-protein-gene-therapy-for-als-idUSFWN1OY0C2", "ord_in_thread": 0, "title": "BRIEF-Sangamo And Pfizer Announce Collaboration For Development Of Zinc Finger Protein Gene Therapy For Als", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "sangamo", "sentiment": "none"}, {"name": "finger protein gene therapy for als reuters staff  jan", "sentiment": "none"}, {"name": "sangamo therapeutics inc", "sentiment": "none"}, {"name": "pfizer", "sentiment": "none"}, {"name": "sangamo therapeutics​ - co", "sentiment": "none"}, {"name": "pfizer inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": " 37 PM / Updated 19 minutes ago BRIEF-Sangamo And Pfizer Announce Collaboration For Development Of Zinc Finger Protein Gene Therapy For Als Reuters Staff \nJan 3 (Reuters) - Pfizer Inc: \n* SANGAMO AND PFIZER ANNOUNCE COLLABORATION FOR DEVELOPMENT OF ZINC FINGER PROTEIN GENE THERAPY FOR ALS \n* SANGAMO THERAPEUTICS​ - CO, ‍PFIZER ANNOUNCED COLLABORATION FOR DEVELOPMENT OF ZINC FINGER PROTEIN GENE THERAPY FOR ALS \n* SANGAMO THERAPEUTICS INC - UNDER TERMS OF COLLABORATION AGREEMENT, SANGAMO WILL RECEIVE A $12 MILLION UPFRONT PAYMENT FROM PFIZER \n* SANGAMO THERAPEUTICS INC - UNDER AGREEMENT, CO ‍WILL BE RESPONSIBLE FOR DEVELOPMENT OF ZFP-TF CANDIDATES​ \n* SANGAMO - UNDER TERMS ELIGIBLE TO RECEIVE POTENTIAL DEVELOPMENT & COMMERCIAL MILESTONE PAYMENTS UP TO $150 MILLION, TIERED ROYALTIES ON NET SALES \n* SANGAMO - UNDER DEAL,‍PFIZER OPERATIONALLY,FINANCIALLY RESPONSIBLE FOR RESEARCH,DEVELOPMENT,COMMERCIALIZATION FOR C9ORF72 ZFP-TF,RESULTING PRODUCTS Source text for Eikon: Further company coverage:", "external_links": [], "published": "2018-01-03T14:36:00.000+02:00", "crawled": "2018-01-03T14:58:40.001+02:00", "highlightTitle": ""}